Technology | 2009.03.11
Advanced Cell Technology Secures $5 Million Credit Facility to Develop RPE Program for the Treatment of Diseases of the Eye
WORCESTER, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT” or the “Company”) (PINKSHEETS: ACTC) announced today that it has entered into a definitive agreement with a life sciences
For more information, please visit
http://www.businesswire.com/news/home/20090311005678/en
